Expansion Opportunity Equitech-Bio recently expanded its reagent portfolio with a new IgG offering and has publication-backed product validation from Bioz, suggesting increased product breadth and credibility. This presents cross-sell potential to existing customers and a foothold to target additional labs seeking validated IgG reagents and related filtration products.

Partnership Potential Recent collaboration with Bioz enhances visibility and credibility for Equitech-Bio’s products. Sales outreach can leverage this partnership to approach biotech researchers and institutions prioritizing validated, publication-backed reagents and performance data.

OEM & Customization With decades as a preferred OEM supplier and capability to handle custom antibody orders and bulk filtration, there is an opportunity to upsell to larger biopharma and diagnostic labs seeking bespoke filtration solutions, faster turnaround, and dedicated support.

Growth Signals Revenue range ($10M–$25M) and a global customer base imply scalable demand for additional catalog expansions, quality filtration technologies, and service offerings. Proactive outreach to mid-size biotechs and research institutions could unlock incremental deals.

Technology & Engagement A tech stack including modern web and marketing tools (WordPress, Shopify, Mailchimp) alongside a proactive customer success approach indicates a structured digital sales motion. Leverage content, case studies, and direct outreach to convert inquiries into orders, while promoting rapid turnaround and high standards.